PharmiWeb

ReiThera to Unveil ReiCell-AAV Platform for High-Efficiency Gene Therapy AAV Production, Adding to MVA and GRAd Vector Capabilities

First look at ReiCell-AAV next week at Advanced Therapies London, Booth 94 With three cutting-edge platforms for gene therapy and genetic vaccine production, ReiThera remains unique among CDMOs Rome, ...
Pharmabiz

ReiThera, Ragon Institute of Mass General, MIT, and Harvard, & IAVI collaborate to advance highly networked T cell HIV vaccine candidate towards phase I clinical evaluation

ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...
Business Insider

ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years

Phase 1 Trial to Advance into Elderly Subjects Aged 65-85 Years ROME, Nov. 24, 2020 /PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and ...
Business Insider

ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years

ROME, Nov. 24, 2020 /PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for ...